Nutrition Support and the Chronic Critical Illness Syndrome

Abstract

Critical illness can be viewed as consisting of 4 distinct stages: (1) acute critical illness (ACI), (2) prolonged acute critical illness, (3) chronic critical illness, and (4) recovery. ACI represents the evolutionarily programmed response to a stressor. In ACI, substrate is shunted away from anabolism and toward vital organ support and inflammatory proteins. Nutrition support in this stage is unproven and may ultimately prove detrimental. As critical illness progresses, there is no evolutionary precedent, and man owes his life to modern critical care medicine. It is at this point that nutrition and metabolic support become integral to the care of the patient. This paper (1) delineates and develops the 4 stages of critical illness using current evidence, clinical experience, and new hypotheses; (2) defines the chronic critical illness syndrome (CCIS); and (3) details an approach to the metabolic and nutrition support of the chronically critically ill patient using the metabolic model of critical illness as a guide. It is our hope that this clinical model can generate testable hypotheses that can improve the outcome of this unique population of patients.

Get full access to this article

View all access options for this article.

References

Goldstein DS, McEwen BS. Allostasis, homeostasis, and the nature of stress. Stress. 2002 ;5:55– 58.

McEwen BS. Interacting mediators of allostasis and allostatic load: toward an understanding of resilience in aging. Metabolism. 2003 ;52(suppl 2):S10– S16.

McEwen BS. Stressed or stressed out: what is the difference? J Psychiatry Neurosci. 2005 ;30:315– 318.

McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003 ;43:2– 15.

Korte SM, Koolhaas JM, Wingfield JC, McEwen BS. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev. 2005;29:3– 38.

Kompan L, Kremzar B, Gadzijec E, Prosek M. Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury. Intensive Care Med. 1999 ;25:157– 161.

Eyer SD, Micon LT, Konstantinides FN, et al. Early enteral feeding does not attenuate metabolic response after blunt trauma. J Trauma. 1993;34:639– 643.

Chuntrasakul C, Siltharm S, Chinswangwatanakul V, Pongprasobchai T, Chockvivatanavanit S, Bunnak A. Early nutritional support in severe traumatic patients. J Med Assoc Thai. 1996 ;79:21– 26.

Singh G, Ram RP, Khanna SK. Early postoperative feeding in patients with nontraumatic intestinal perforation and peritonitis. J Am Coll Surg. 1998;187:142– 146.

10.

Ibrahim EH, Mehringer L, Prentice D, et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr. 2002 ;26:182– 183.

11.

Minard G, Kudsk KA, Metlon S, Patton JH, Tolley EA. Early versus delayed feeding with an immune-enhancing diet in patients with severe head injuries. JPEN J Parenter Enteral Nutr. 2000 ;24:145– 149.

12.

Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma: a prospective, randomized study. J Trauma. 1986;26:874– 881.

13.

Chiarelli A, Enzi G, Casadei A, Baggio B, Valerio A, Mazzoleni F. Very early nutrition supplementation in burned patients. Am J Clin Nutr. 1990;51:1035– 1039.

14.

Heyland DK, Rupinder D, Drover JW, Gramlich L, Dodek P, Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27:355– 373.

15.

Wernerman J. Guidelines for nutritional support in intensive care patients: a critical analysis. Curr Opin Clin Nutr Metab Care. 2005;8:171– 175.

16.

Van den Berghe G, de Zegher F, Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab. 1998;83:1827– 1834.

17.

Van den Berghe G. Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin. 2002 ;18:509– 528.

18.

Vanhorebeek I, Van den Berghe G. The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin. 2006 ;22:1– 15.

19.

Van den Berghe G. Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin North Am. 2003 ;32:385– 410.

20.

Van den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol. 2002 ;23:370– 391.

21.

Van den Berhe G. The neuroendocrine stress response and modern intensive care: the concept revisited. Burns. 1999 ;25:7– 16.

22.

Bornstein SR, Chrousos GP. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab. 1999 ;84:1729– 1736.

23.

Vermes I, Beishhuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab. 2001;15:495– 511.

24.

Chung TT, Hinds CJ. Treatment with GH and IGF-1 in critical illness. Crit Care Clin. 2006 ;22:29– 40.

25.

Peeters RP, Debaveye Y, Fliers E, Visser TJ. Changes within the thyroid axis during critical illness. Crit Care Clin. 2006 ;22:41– 55.

26.

De Groot L. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006;22:57– 86.

27.

Van den Berghe G, Wouters P, Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab. 1999 ;84:1311– 1323.

28.

Mayr S, Walz C, Angele P, et al. Castration prevents suppression of MHC class II (Ia) expression on macrophages following trauma-hemorrhage. J Appl Physiol. 2006 ;101:448– 453.

29.

Angele MK, Ayala A, Monfils BA, Cioffi WG, Bland KI, Chaudry IH. Testosterone and/or low estradiol: normally required but harmful immunologically for males after trauma-hemorrhage. J Trauma. 1998;44:78– 85.

30.

Frankenfield DC, Smith JS, Cooney RN. Accelerated nitrogen loss after traumatic injury is not attenuated by achievement of energy balance. JPEN J Parenter Enteral Nutr. 1997 ;21:324– 329.

31.

Schwarz JM, Chiolero R, Revelly JP, et al. Effects of enteral carbohydrates on de novo lipogenesis in critically ill patients. Am J Clin Nutr. 2000;72:940– 945.

32.

Buchman T. Nonlinear dynamics, complex systems, and the pathobiology of critical illness. Curr Opin Crit Care. 2004 ;10:378– 382.

33.

Carson SS, Back PB. The epidemiology and costs of chronic critical illness. Crit Care Clin. 2002 ;18:461– 476.

34.

Nelson JE, Meier DE, Litke A, Natale DA, Siegel RE, Morrison RS. The symptom burden of chronic critical illness. Crit Care Med. 2004;32:1617– 1618.

35.

Gamrin L, Essen P, Forsberg AM, Hultman E, Wernerman J. A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med. 1996 ;24:575– 583.

36.

Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest. 1998 ;114:1122– 1128.

37.

Van den Berhe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003 ;88:4623– 4632.

38.

Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 ;354:449– 461.

39.

Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001 ;345:1359– 1367.

40.

Kalb T, Lorin S. Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin. 2002;18:529– 552.

41.

Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003 ;31:1279– 1280.

42.

Brem H, Nierman D, Nelson J. Pressure ulcers in the chronically critically ill patient. Crit Care Clin. 2002 ;18:683– 694.

43.

Wolfe R. Regulation of skeletal protein metabolism in catabolic states. Cur Opin Clin Nutr Metab Care. 2005 ;8:61– 65.

44.

Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 1987;27:262– 266.

45.

Mechanick JI. Metabolic mechanisms of stress hyperglycemia. JPEN J Parenter Enteral Nutr. 2006 ;30:157– 163.

46.

Langouche L, Van den Berhe G. Glucose metabolism and insulin therapy. Crit Care Clin. 2006 ;22:119– 129.

47.

Hausenloy DH, Yellon DM. New directions for protecting the heart against ischemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res. 2004 ;61:448– 460.

48.

Le Roith D. Molecular mechanisms by which metabolic control may improve outcomes. Endocr Pract. 2004 ;10(suppl 2):57– 62.

49.

Nierman DM, Mechanick JI. Blood glucose control in the post-ICU respiratory care unit [abstract]. Chest.2003 ;124:176S .

50.

Nierman DM, Mechanick JI. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest. 2000;118:761– 766.

51.

Sato Y, Kanoko T, Satoh K, Iwamoto J. The prevention of hip fracture with risedronate and ergocalciferal plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med. 2005 ;165:1737– 1742.

52.

Walter LC, Lui LY, Covinsky KE. Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc. 2003 ;51:50– 55.

53.

Spicher JE, White DP. Outcome and function following prolonged mechanical ventilation. Arch Intern Med. 1987 ;147:421– 425.

54.

Gracey DR, Naessens JM, Krishnan I, Marsh HM. Hospital and posthospital survival in patients mechanically ventilated for more than 29 days. Chest. 1992 ;101:211– 214.

55.

Mechanick JI. Practical aspects of nutritional support for wound-healing patients. Am J Surg. 2004 ;188(1A suppl):52– 56.

56.

Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005 ;11:126– 132.

57.

Latronico N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med. 2003 ;29:1411– 1413.

58.

Scagg P, Jones A, Fauvel N. Psychological problems following ICU treatment. Anaesthesia. 2001 ;56:9– 14.

59.

McEwan B. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004 ;1032:1– 7.

60.

Woodcock NP, Zeigler D, Palmer MD, Buckley P, Mitchell CJ, MacFie J. Enteral versus parenteral nutrition: a pragmatic study. Nutrition. 2001 ;17:1– 12.

61.

Pingleton SK. Nutrition in chronic critical illness. Clin Chest Med. 2001 ;22:149– 163.

62.

Robert S, Zarowitz BJ, Hyzy R, Eichenhorn M, Petersen EL, Popovich J Jr. Bioelectrical impedance assessment of nutritional status in critically ill patients. Am J Clin Nutr. 1993 ;57:840– 844.

63.

Faisy C, Rabbat A, Kouchakji B, Laaban JP. Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med. 2000 ;26:518– 525.

64.

Seres DS. Surrogate nutrition markers, malnutrition, and adequacy of nutrition support. Nutr Clin Pract. 2005 ;20:291– 293.

65.

Sung J, Bochicchio GV, Joshi M, et al. Admission serum albumin is predictive of outcome in critically ill trauma patients. Am Surg. 2004;70:1099– 1102.

66.

Kudsk KA, Tolley EA, DeWitt RC, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003 ;27:1– 9.

67.

Murray MJ, Marsh HM, Wochos DN, Moxness KE, Offord KP, Callaway CW. Nutritional assessment of intensive-care patients. Mayo Clin Proc. 1988;63:1106– 1115.

68.

Casati A, Muttini S, Leggieri C, Colombo S, Giorgi E, Torri G. Rapid turnover proteins in critically ill ICU patients: negative acute phase proteins or nutritional indicators? Minerva Anestesiol. 1998;64:345– 350.

69.

Nataloni S, Gentili P, Marini B, et al. Nutritional assessment in head injured patients through study of rapid turnover visceral proteins. Clin Nutr. 1999 ;18:247– 251.

70.

Lim SH, Lee JS, Chae SH, et al. Prealbumin is not a sensitive indicator of nutrition and prognosis in critically ill patients. Yonsei Med J. 2005 ;46:21– 26.

71.

Nierman DM, Mechanick JI, Begonia MA, et al. Improvement in albumin but not prealbumin is associated with outcome of chronically critically ill patients [abstract]. Am J Respir Crit Care Med. 1997 ;155:A774 .

72.

Kuzu MA, Terzioglu H, Gene V, et al. Preoperative nutritional risk assessment in predicting postoperative outcome in patients undergoing major surgery. World J Surg. 2006 ;30:378– 390.

73.

Bouillanne O, Morineau G, Dupont C, et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005 ;82:777– 783.

74.

Reid C. Nutritional requirements of surgical and critically ill patients: do we really know what they need? Proc Nutr Soc. 2004;63:467– 472.

75.

Hoffer LJ. Protein and energy provision in critical illness. Am J Clin Nutr. 2003 ;78:906– 911.

76.

Tappy L, Berger M, Schwarz JM, et al. Hepatic and peripheral glucose metabolism in intensive care patients receiving continuous high- or low-carbohydrate enteral nutrition. JPEN J Parenter Enteral Nutr. 1999;23:260– 267.

77.

Cerra FB, Benitez MR, Blackburn GL, et al. Applied nutrition in ICU patients: a consensus statement of the American College of Chest Physicians. Chest. 1997;111:769– 778.

78.

Krishnan J, Parce P, Martinez A, Diette G, Roy G. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003 ;124:297– 305.

79.

Krenitsky J. Adjusted body weight, pro: evidence to support the use of adjusted body weight in calculating calorie requirements. Nutr Clin Pract. 2005;20:468– 473.

80.

Mechanick JI, Chiolero R. Nutrition support in critically ill patients: switching to evidence based. Curr Opin Clin Nutr Metab Care. 2006;9:117– 119.

81.

Roy CC, Bouthillier L, Seidman E, Levy E. New lipids in enteral feeding. Curr Opin Clin Nutr Metab Care. 2004 ;7:117– 122.

82.

Faucher M, Bregeon F, Gainnier M, Thirion X, Auffray JP, Papazian L. Cardiopulmonary effects of lipid emulsions in patients with ARDS. Chest. 2003;124:285– 291.

83.

Lindgren BF, Ruokonen E, Magnusson-Borg K, Takala J. Nitrogen sparing effect of structured triglycerides containing both medium- and long-chain fatty acids in critically ill patients: a double blind randomized controlled trial. Clin Nutr. 2001 ;20:43– 48.

84.

Craig GB, Darnell BE, Weinsier RL, et al. Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formulas vs those receiving long-chain-triglyceride-containing formula. J Am Diet Assoc. 1997;97:605– 611.

85.

McClave SA, Lowen CC, Kleber MJ, et al. Are patients fed appropriately according to their caloric requirements? JPEN J Parenter Enteral Nutr. 1998 ;22:375– 381.

86.

Reid C. Frequency of under- and overfeeding in mechanically ventilated ICU patients: causes and possible consequences. J Hum Nutr Diet. 2006;19:13– 22.

87.

Mechanick JI, Brett EM. Nutrition and the chronically critically ill patient. Curr Opin Clin Nutr Metab Care. 2005 ;8:33– 39.

88.

McClave SA, Kleber MJ, Lowen CC. Indirect calorimetry: can this technology impact patient outcome? Curr Opin Clin Nutr Metab Care. 1999;2:61– 67.

89.

Harris JA, Benedict FG. A Biometric Study of Basal Metabolism in Man. Washington, DC: Carnegie Institute of Washington; 1919. Publication No. 279.

90.

Ireton-Jones C, Jones JD. Improved equations for predicting energy expenditure in patients: the Ireton-Jones equations. Nutr Clin Pract. 2002;17:29– 31.

91.

Liu HY, Lu YF, Chen WJ. Predictive equations for basal metabolic rate in Chinese adults: a cross-validation study. J Am Diet Assoc. 1995;12:1403– 1408.

92.

McClave SA, Snider HL, Ireton-Jones C. Can we justify continued interest in indirect calorimetry? Nutr Clin Pract. 2002 ;17:133– 136.

93.

Green CJ, Campbell IT, McClelland P, et al. Energy and nitrogen balance and changes in midupper-arm circumference with multiple organ failure. Nutrition. 1995 ;11:739– 746.

94.

Reid C, Campbell I. High energy deficits in MODS patients are associated with prolonged length of stay but not mortality. Clin Nutr. 2001;(suppl 20):A133 .

95.

Ishibashi N, Plank LD, Sando K, Hill GL. Optimal protein requirements during the first 2 weeks after the onset of critical illness. Crit Care Med. 1998 ;26:1529– 1535.

96.

Barr J, Hecht M, Flavin K, Khorana A, Gould M. Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest. 2004 ;125:1446– 1447.

97.

Dwolatzky T, Berezovski S, Friedmann R, et al. A prospective comparison of the use of nasogastric and percutaneous endoscopic gastrostomy tubes for long-term enteral feeding in older people. Clin Nutr. 2001;20:535– 540.

98.

Kirby DF, Delegge MH, Fleming CR. American Gastroenterological Association Medical Position Statement: guidelines for the use of enteral nutrition. Gastroenterology. 1995 ;108:1280– 1301.

99.

Montejo JC, Grau T, Acosta J, et al. Multicenter, prospective, randomized, single-blind study comparing the efficacy and gastrointestinal complications of early jejunal feeding with early gastric feeding in critically ill patients. Crit Care Med. 2002 ;30:796– 800.

100.

Davies AR, Froomes PR, French CJ. Randomized comparison of nasojejunal and nasogastric feeding in critically ill patients. Crit Care Med. 2002 ;30:586– 590.

101.

Kearns PJ, Chin D, Mueller L, Wallace K, Jensen WA, Kirsch CM. The incidence of ventilator-associated pneumonia and success in nutrient delivery with gastric versus small intestinal feeding: a randomized clinical trial. Crit Care Med. 2000 ;28:1742– 1746.

102.

Cresci G, Martindale R. Bedside placement of small bowel feeding tubes in hospitalized patients: a new role for the dietitian. Nutrition. 2003 ;19:843– 846.

103.

Jimenez LL, Ramage JE Jr. Benefits of postpyloric enteral access placement by a nutrition support dietitian. Nutr Clin Pract. 2004;19:518– 522.

104.

Schloerb PR, Wood JG, Casillan AJ, Tawfik O, Udobi K. Bowel necrosis caused by water in jejunal feeding. JPEN J Parenter Enteral Nutr. 2004;28:27– 29.

105.

McClave SA, Sexton LK, Spain DA, et al. Enteral tube feeding in the intensive care unit: factors impeding adequate delivery. Crit Care Med. 1999;27:1383– 1384.

106.

Kemper M, Weissman C, Hyman AI. Caloric requirements and supply in critically ill surgical patients. Crit Care Med. 1997 ;20:344– 348.

107.

Heyland D, Cook DJ, Winder B. Enteral nutrition in the critically ill patient: a prospective survey. Crit Care Med. 1995 ;23:1055– 1060.

108.

Binnekade JM, Tepaske R, Bruynzeel P, Mathus-Vliegen EM, de Hann RJ. Daily enteral feeding practice in the ICU: attainment of goals and interfering factors.2005 ;9:R218– R225.

109.

Villet S, Chiolero R, Bollman M, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005 ;24:502– 509.

110.

Bauer P, Charpentier C, Bouchet C, Nace L, Raffy G, Gaconnet N. Parenteral with enteral nutrition in the critically ill. Intensive Care Med. 2000;26:893– 900.

111.

Simpson F, Doig GS. Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive Care Med. 2005 ;31:12– 23.

112.

Mortelmans AK, Duym P, Vanderbrouke J, et al. Intradialytic parenteral nutrition in malnourished hemodialysis patients: a prospective long-term study. JPEN J Parenter Enteral Nutr. 1999 ;23:90– 95.

113.

Burkart J. Metabolic consequences of peritoneal dialysis. Semin Dial. 2004 ;17:498– 504.

114.

Hwang TL, Lue MC, Jan YY, Chen MF. The incidence of diarrhea in patients with hypoalbuminemia due to acute or chronic malnutrition during enteral feeding. Am J Gastroenterol. 1994 ;89:376– 378.

115.

Heimburger DC, Geels VJ, Bilbrey J, Redden DT, Keeney C. Effects of small-peptide and whole-protein enteral feedings on serum proteins and diarrhea in critically ill patients: a randomized trial. JPEN J Parenter Enteral Nutr. 1997 ;21:162– 167.

116.

Ziegler F, Ollivier JM, Cynober L, et al. Efficiency of enteral nitrogen support in surgical patients: small peptides v nondegraded proteins. Gut. 1990;31:1277– 1283.

117.

Meredith JW, Ditesheim JA, Zaloga GP. Visceral protein levels in trauma patients are greater with peptide diet than with intact protein diet. J Trauma. 1990;30:825– 528.

118.

Ortiz C, Candau P, Arock M, et al. A comparative post-operative study: an enteral solution based on small peptides compared to an enteral solution based on free amino acids. Gastroenterol Clin Biol. 1985;9:182– 190.

119.

Kieft H, Roos A, van Drunen J, Bindels AJ, Bindels, JG, Hofman Z. Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med. 2005 ;31:524– 532.

120.

Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled trial of enteral immunonutrition in the critically ill: Guy's Hospital Intensive Care Group. Crit Care Med. 1998;26:1164– 1172.

121.

Galban C, Montejo JC, Mesejo A, et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care patients. Crit Care Med. 2000 ;28:643– 648.

122.

Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma: an immuneenhancing diet reduces septic complications. Ann Surg. 1996 ;224:531– 540.

123.

Bertolini G, Iapichino G, Radrizzani D, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicenter clinical trial. Intensive Care Med. 2003;29:834– 840.

124.

Mechanick JI. Parenteral nutrition formulation: an integral part of the endocrinologist's metabolic support consultation service. Endocr Pract. 1996 ;2:197– 203.

125.

McMahon MM. Management of hyperglycemia in hospitalized patients receiving parenteral nutrition. Nutr Clin Pract. 1997 ;12:35– 38.

126.

Guenter PA, Settle RG, Perlmutter S, Marino PL, DeSimone GA, Rolandelli RH. Tube feeding-related diarrhea in acutely ill patients. JPEN J Parenter Enteral Nutr. 1991 ;15:277– 280.

127.

Montejo JC. Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. Crit Care Med. 1999;27:1447– 1453.

128.

Caines C, Gill MV, Cunha B. Non-Clostridium difficile nosocomial diarrhea in the intensive care unit. Heart Lung. 1997;26:83– 84.

129.

Mechanick JI, Brett EM. Nutrition support of the chronically critically ill patient. Crit Care Clin. 2002 ;18:597– 618.

130.

Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92:739– 750.

131.

Bengmark S. Use of some pre-, pro- and symbiotics in critically ill patients. Best Pract Res Clin Gastroenterol. 2003 ;17:833– 848.

132.

Mechanick JI, Brett EM, Chausmer AB, Dickey RA, Wallach S. American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. Endocr Practice. 2003;9:417– 470.

133.

Owens RC. Clostridium difficile-associated disease: an emerging threat to patients safety: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2006 ;26:299– 311.

134.

Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol. 2000 ;95(suppl 1):S11– S13.

135.

Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006 ;12:PI19– PI22.

136.

Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhea. Int Microbiol. 2004;7:59– 62.

137.

Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis . 2000;31:1012– 1017.

138.

Lherm T, Monet C, Nougiere B, et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 2002 ;28:797– 801.

139.

Cassone M, Serra P, Mondello F, et al. Outbreak of Saccharomyces cerevisae subtype boulardii fungemia in patients neighboring those treated with probiotic preparation of the organism. J Clin Microbiol. 2003 ;41:5340– 5343.

140.

Marik P, Zaloga G. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest. 2002 ;122:1784– 1796.

141.

Mechanick JI, Brett EM. Endocrine and metabolic issues in the management of the chronically critically ill patient. Crit Care Clin. 2002;18:619– 641.

142.

National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 suppl 3): S1–S201.

143.

Grant W, Holick M. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 ;10:94– 111.

144.

Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 ;80(suppl):1678S– 1688S.

145.

Zazzo JF, Troche G, Ruel P, Maintenant J. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorous therapy on myocardial function. Intensive Care Med. 1995 ;21:826– 831.

146.

Cohen J, Kogan A, Sahar G, Lev S, Vidne B, Singer P. Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg. 2004 ;26:306– 310.

147.

Rimaniol JM, Authier FJ, Chariot P. Muscle weakness in intensive care patients: initial manifestation of vitamin D deficiency. Intensive Care Med. 1994 ;20:591– 592.

148.

Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006;17:897– 907.

149.

Teitelbaum SL, Hruska KA. Renal osteodystrophy. N Engl J Med. 1995;333:166– 174.

150.

Bergner R, Dill K, Boerner D, Uppenkamp M. Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study. Nephrol Dial Transplant. 2002 ;17:1281– 1285.

151.

Farrugia MC, Summerlin DJ, Krowiak E, et al. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope. 2006 ;116:115– 120.

152.

Hammarqvist F, Wernerman J, Ali R, von der Decken A, Vimnars E. Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann Surg. 1989;209:455– 461.

153.

Newsholme EA, Crabtree B, Ardawi MS. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol. 1985 ;70:473– 489.

154.

Peng X, Yan H, You Z, Wang P, Wang S. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severely burned patients. Burns. 2004 ;30:135– 139.

155.

Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandrsta DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001 ;27:84– 90.

156.

Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition. 1999 ;15:108– 115.

157.

Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R. A prospective trial of enteral glutamine in critical illness. Intensive Care Med. 2003 ;29:1710– 1716.

158.

Schulman AS, Willcutts KF, Claridge JA, et al. Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med. 2005;33:2501– 2506.

159.

Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 2005 ;31:1079– 1086.

160.

Griffiths RD, Jones C, Palmer TF. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 1997 ;13:295– 302.

161.

Novak F, Heyland D, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002 ;30:2022– 2029.

162.

Bourdel-Marchasson I, Barateau M, Rondeau V, et al. A multicenter trial of the effects of oral nutritional supplementation in critically ill older patients. Nutrition. 2000 ;16:1– 5.

163.

Chernoff RS, Milton KY, Lipschitz DA, et al. The effect of a very high-protein liquid formula on decubitus ulcers healing in long-term tube-fed institutionalized patients [abstract]. J Am Diet Assoc. 1990;90:A-130 .

164.

Breslow RA, Hallfrisch J, Guy DG, Crawley B, Goldberg AP. The importance of dietary protein in healing pressure ulcers. J Am Geriatr Soc. 1993;41:357– 362.

165.

Lee SK, Posthauer ME, Dorner B, Redovian V, Maloney MJ. Pressure ulcer healing with a concentrated, fortified, collagen protein hydrolysate supplement: a randomized controlled trial. Adv Skin Wound Care. 2006;19:92– 96.

166.

Kirk SJ, Hurson M, Regan MC, Holt DR, Wasserkrug HL, Barbul A. Arginine stimulates wound healing and immune function in elderly human beings. Surgery. 1993;114:155– 159.

167.

De Luis SA, Izaola O, Cuellar L, Terroba MC, Aller R. Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients. Eur J Clin Nutr. 2004 ;58:1505– 1508.

168.

Desneves K, Todorovic B, Cassar A, Crowe T. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomized controlled trial. Clin Nutr. 2005 ;24:979– 987.

169.

Taylor TC, Rimmer S, Day B, Butcher J, Dymock IW. Ascorbic acid supplementation in the treatment of pressure sores. Lancet. 1974;2:544– 546.

170.

ter Riet G, Kessels AG, Knipschild PG. Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers. J Clin Epidemiol. 1995;48:1453– 1460.

171.

Voerman BJ, Strack van Schijndel RJ, Groeneveld AB, de Boer H, Nauta JP, Thijs LG. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo controlled trial. Crit Care Med. 1995 ;23:665– 673.

172.

Gamrin L, Essen P, Hultman E, McNurlan MA, Garlick PJ, Wernerman J. Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Ann Surg. 2000 ;231:577– 586.

173.

Kissmeyer-Nielsen P, Jensen MB, Laurberg S. Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg. 1999 ;229:298– 302.

174.

Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999 ;341:785– 792.

175.

Benito M, Vasilic B, Wehrli FW, et al. Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res. 2005;20:1785– 1791.

176.

Zachwieja JJ, Smith SR, Lovejoy JC, Rood JC, Windhauser MM, Bray GA. Testosterone administration preserves protein balance but not muscle strength during 28 days of bed rest. J Clin Endocrinol Metab. 1999;84:207– 212.

177.

Mechanick JI, Nierman DM. Gonadal steroids in critical illness. Crit Care Clin. 2006 ;22:87– 103.

178.

Murphy KD, Thomas S, Mlcak RP, Chinkes DL, Klein GL, Herndon DN. Effects of long-term oxandralone administration in severely burned children. Surgery. 2004;136:219– 224.

179.

Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res. 2006 ;27:131– 139.

180.

Bulger EM, Jurkovich GJ, Farver CL, Klotz P, Maier RV. Oxandrolone does not improve outcome of ventilator dependent surgical patients. Ann Surg. 2004 ;240:472– 478.

181.

Van den Berghe G, Baxter RC, Weekers F, et al. The combined administration of GH-releasing peptide-2, TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol. 2002 ;56:655– 669.